PHASE I/II TRIAL OF TEMOZOLOMIDE (TMZ), MOTEXAFIN GADOLINIUM (MGD), AND 60-GY FRACTIONATED RADIATION (RT) FOR NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA: RESULTS OF RTOG 0513 PHASE I DOSE ESCALATION TOXICITY ANALYSIS Conference

Brachman, David, Wang, Meihua, Ashby, Lynn et al. (2008). PHASE I/II TRIAL OF TEMOZOLOMIDE (TMZ), MOTEXAFIN GADOLINIUM (MGD), AND 60-GY FRACTIONATED RADIATION (RT) FOR NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA: RESULTS OF RTOG 0513 PHASE I DOSE ESCALATION TOXICITY ANALYSIS . NEURO-ONCOLOGY, 10(5), 889-889.

cited authors

  • Brachman, David; Wang, Meihua; Ashby, Lynn; Stea, Baldassarre; Thomas, Theresa; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 20, 2008 -

publication date

  • October 1, 2008

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Las Vegas, NV

Conference

  • 13th Annual Meeting of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 889

end page

  • 889

volume

  • 10

issue

  • 5